Skip to main content
An official website of the European UnionAn official EU website
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

MONITOR RESPIRATORY HEALTH USING VOICE

Project description

Vocal biomarkers for advanced health monitoring and disease prediction

The human voice holds secrets that science is only beginning to unlock. In fact, every breath we take carries hidden clues about our health. With this in mind, a groundbreaking initiative aims to harness these auditory signals for advanced health monitoring and disease prediction. The EU-funded VoiceMed-WomenTechEU project fuses vocal biomarkers, sound analysis, and AI to decode health mysteries concealed within our breathing. It deciphers subtle signals embedded within vocal sounds, transcending conventional parameters like wheezes or crackles. This enables seamless, instantaneous, and remote assessment, poised to revolutionise patient care. On the brink of a voice-powered medical revolution, the project resonates as a beacon of hope for enhanced healthcare.

Objective

Voice can tell a lot of information about our health. We believe that voice is the new blood for medical diagnosis.

Asthma is a long-term disease that affects the lungs and airways. It is one of the most common chronic diseases with 5.8% of the EU population suffering from asthma - ~30 mill people. Doctors have always relied on the patient’s voice as one of the first parameters to assess health. When they talk to a patient, they carefully listen to their breathing, cough, and speech looking for specific signs. However, doctors usually evaluate patients without using any digital solution, leading to a 50% rate in non-well-controlled patients.

Deep-tech innovation: VoiceMed uses vocal biomarkers combined with sound analysis and artificial intelligence. Our technology detects subtle signals in the sounds produced by the vocal apparatus. When the association between a signal either a normal biological or pathogenic state is fully validated, these signals become vocal biomarkers. This process allows going beyond the sounds routinely used in medical practice, such as wheezes or crackles, and unlocking a new dimension of biomarkers that can be assessed remotely, instantaneously and with no extra equipment.

Women Founders:
Arianna Arienzo (CEO) - +6 years experience in business in 5 countries (including Silicon Valley). Entrepreneur in digital health and digital technologies. Listed in Forbes Under 30 in 2022. Contract professor at Cattolica university in healthcare innovation. Msc business administration.
Dr. Ayana de Brito (CSO) - +9 years’ experience as a research scientist in computational biology, currently leading our research team. She has skills in scientific practices, scientific writing, pm, strategic planning, data analysis, statistics, data visualization and programming. She is an expert also in regulatory affairs, with knowledge also in privacy. PhD in computational biologist.

Coordinator

VOICEMED SARL
Net EU contribution
€ 75 000,00
Address
ROUTE D'ARLON 98
8008 Strassen
Luxembourg

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Luxembourg Luxembourg Luxembourg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data